ID   HO-8910PM
AC   CVCL_0310
SY   HO-8910 PM; HO8910-PM; HO8910-pm; HO8910/PM; HO8910PM; HO8910pm
DR   BTO; BTO:0005772
DR   MCCL; MCC:0000203
DR   Wikidata; Q38151257
RX   PubMed=10464713;
RX   PubMed=11930655;
RX   PubMed=25502083;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative (CCRID).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00607.
CC   Population: African American.
CC   Characteristics: Established from a 7th generation nude mice xenograft originating from HO-8910.
CC   Doubling time: 34.5 hours (PubMed=10464713).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Transcriptome analysis by microarray.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0001CCC000281, 3131C0001000700025). They were the sole source for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,17,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6868 ! HO-8910
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 18
//
RX   PubMed=10464713;
RA   Xu S.-H., Qin L.-J., Mou H.-Z., Ni X.-H., Zhu C.-H., Zhang G.,
RA   Dai W.-F., Gao Y.-L.;
RT   "Establishment of a highly metastatic human ovarian cancer cell line
RT   (HO-8910PM) and its characterization.";
RL   J. Exp. Clin. Cancer Res. 18:233-239(1999).
//
RX   PubMed=11930655; DOI=10.3760/cma.j.issn.0366-6999.2002.01.107;
RA   Xu S.-H., Mou H.-Z., Lu G.-Q., Zhu C.-H., Yang Z.-Y., Gao Y.-L.,
RA   Lou H.-K., Liu X.-L., Cheng Y., Yang W.;
RT   "Gene expression profile differences in high and low metastatic human
RT   ovarian cancer cell lines by gene chip.";
RL   Chin. Med. J. 115:36-41(2002).
//
RX   PubMed=25502083; DOI=10.1007/s12032-014-0426-5;
RA   Zhu L.-C., Hu Z.-H., Liu J.-J., Gao J., Lin B.;
RT   "Gene expression profile analysis identifies metastasis and
RT   chemoresistance-associated genes in epithelial ovarian carcinoma
RT   cells.";
RL   Med. Oncol. 32:426.1-426.13(2015).
//